Literature DB >> 26994063

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Miguel A Hernán, James M Robins.   

Abstract

Ideally, questions about comparative effectiveness or safety would be answered using an appropriately designed and conducted randomized experiment. When we cannot conduct a randomized experiment, we analyze observational data. Causal inference from large observational databases (big data) can be viewed as an attempt to emulate a randomized experiment-the target experiment or target trial-that would answer the question of interest. When the goal is to guide decisions among several strategies, causal analyses of observational data need to be evaluated with respect to how well they emulate a particular target trial. We outline a framework for comparative effectiveness research using big data that makes the target trial explicit. This framework channels counterfactual theory for comparing the effects of sustained treatment strategies, organizes analytic approaches, provides a structured process for the criticism of observational studies, and helps avoid common methodologic pitfalls.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  big data; causal inference; comparative effectiveness research; target trial

Mesh:

Substances:

Year:  2016        PMID: 26994063      PMCID: PMC4832051          DOI: 10.1093/aje/kwv254

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010-03-03       Impact factor: 0.968

3.  Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Til Stürmer; M Alan Brookhart; Jerry Avorn; Malcolm Maclure; Kenneth J Rothman; Robert J Glynn
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

4.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  J Clin Epidemiol       Date:  2009-05       Impact factor: 6.437

5.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

6.  A targeted maximum likelihood estimator for two-stage designs.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-11       Impact factor: 0.968

7.  Beyond the intention-to-treat in comparative effectiveness research.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Clin Trials       Date:  2011-09-23       Impact factor: 2.486

8.  The well-built clinical question: a key to evidence-based decisions.

Authors:  W S Richardson; M C Wilson; J Nishikawa; R S Hayward
Journal:  ACP J Club       Date:  1995 Nov-Dec

9.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

10.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

View more
  343 in total

1.  A tool for empirical equipoise assessment in multigroup comparative effectiveness research.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-27       Impact factor: 2.890

2.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

3.  Accuracy of claims-based algorithms for epilepsy research: Revealing the unseen performance of claims-based studies.

Authors:  Lidia M V R Moura; Maggie Price; Andrew J Cole; Daniel B Hoch; John Hsu
Journal:  Epilepsia       Date:  2017-02-15       Impact factor: 5.864

4.  Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.

Authors:  Andrew R Zullo; Tingting Zhang; Yoojin Lee; Kevin W McConeghy; Lori A Daiello; Douglas P Kiel; Vincent Mor; Sarah D Berry
Journal:  J Am Geriatr Soc       Date:  2018-12-21       Impact factor: 5.562

Review 5.  From Epidemiologic Knowledge to Improved Health: A Vision for Translational Epidemiology.

Authors:  Michael Windle; Hojoon D Lee; Sarah T Cherng; Catherine R Lesko; Colleen Hanrahan; John W Jackson; Mara McAdams-DeMarco; Stephan Ehrhardt; Stefan D Baral; Gypsyamber D'Souza; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

6.  Diagnosing Covariate Balance Across Levels of Right-Censoring Before and After Application of Inverse-Probability-of-Censoring Weights.

Authors:  John W Jackson
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

7.  Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes.

Authors:  Matthew J O'Brien; Susan L Karam; Amisha Wallia; Raymond H Kang; Andrew J Cooper; Nicola Lancki; Margaret R Moran; David T Liss; Theodore A Prospect; Ronald T Ackermann
Journal:  JAMA Netw Open       Date:  2018-12-07

8.  Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

Authors:  Yi Zhang; Jessica G Young; Mae Thamer; Miguel A Hernán
Journal:  Health Serv Res       Date:  2017-05-30       Impact factor: 3.402

9.  Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Authors:  Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-10-20

10.  PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers.

Authors:  Luis Martí-Bonmatí; Ángel Alberich-Bayarri; Ruth Ladenstein; Ignacio Blanquer; J Damian Segrelles; Leonor Cerdá-Alberich; Polyxeni Gkontra; Barbara Hero; J M García-Aznar; Daniel Keim; Wolfgang Jentner; Karine Seymour; Ana Jiménez-Pastor; Ismael González-Valverde; Blanca Martínez de Las Heras; Samira Essiaf; Dawn Walker; Michel Rochette; Marian Bubak; Jordi Mestres; Marco Viceconti; Gracia Martí-Besa; Adela Cañete; Paul Richmond; Kenneth Y Wertheim; Tomasz Gubala; Marek Kasztelnik; Jan Meizner; Piotr Nowakowski; Salvador Gilpérez; Amelia Suárez; Mario Aznar; Giuliana Restante; Emanuele Neri
Journal:  Eur Radiol Exp       Date:  2020-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.